Praveen Thokala Health Economics and Decision Science, School of Health and Related Research University of Sheffield Biography Publications Institution JoVE Articles Praveen Thokala has not added a biography. If you are Praveen Thokala and would like to personalize this page please email our Author Liaison for assistance. Publications Clinical and Economic Impact of a Two-layer Compression System for the Treatment of Venous Leg Ulcers: A Systematic Review Wounds : a Compendium of Clinical Research and Practice. Jan, 2020 | Pubmed ID: 32155127 Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review PharmacoEconomics. 03, 2020 | Pubmed ID: 31820294 The Effectiveness and Value of Treatments for Spinal Muscular Atrophy Journal of Managed Care & Specialty Pharmacy. Dec, 2019 | Pubmed ID: 31778620 Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. Nov, 2019 | Pubmed ID: 31708065 A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement Medical Decision Making : an International Journal of the Society for Medical Decision Making. 11, 2019 | Pubmed ID: 31707911 Transparency in Health Economic Modeling: Options, Issues and Potential Solutions PharmacoEconomics. 11, 2019 | Pubmed ID: 31591672 Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models Medical Decision Making : an International Journal of the Society for Medical Decision Making. 10, 2019 | Pubmed ID: 31431188 Direct Medical Costs in the Preceding, Event and Subsequent Years of a First Severe Hypoglycaemia Episode Requiring Hospitalization: A Population-based Cohort Study Diabetes, Obesity & Metabolism. 06, 2019 | Pubmed ID: 30737873 Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal PharmacoEconomics. 01, 2019 | Pubmed ID: 29951793 Incorporating MCDA into HTA: Challenges and Potential Solutions, with a Focus on Lower Income Settings Cost Effectiveness and Resource Allocation : C/E. 2018 | Pubmed ID: 30455602 Stakeholder Involvement in Multi-Criteria Decision Analysis Cost Effectiveness and Resource Allocation : C/E. 2018 | Pubmed ID: 30455597 Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. 09, 2018 | Pubmed ID: 30224103 Interventions to Improve Patient Flow in Emergency Departments: an Umbrella Review Emergency Medicine Journal : EMJ. Oct, 2018 | Pubmed ID: 30093379 The ACUTE (Ambulance CPAP: Use, Treatment Effect and Economics) Feasibility Study: a Pilot Randomised Controlled Trial of Prehospital CPAP for Acute Respiratory Failure Pilot and Feasibility Studies. 2018 | Pubmed ID: 29946477 Cost-benefit Analysis of Introducing Next-generation Sequencing (metagenomic) Pathogen Testing in the Setting of Pyrexia of Unknown Origin PloS One. 2018 | Pubmed ID: 29664913 Direct Medical Costs of Diabetes Mellitus in the Year of Mortality and Year Preceding the Year of Mortality Diabetes, Obesity & Metabolism. 06, 2018 | Pubmed ID: 29430799 Cost-Effectiveness Thresholds: the Past, the Present and the Future PharmacoEconomics. 05, 2018 | Pubmed ID: 29427072 Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal PharmacoEconomics. 01, 2018 | Pubmed ID: 28770452 Cost-effectiveness of Antibiotic Treatment of Uncomplicated Urinary Tract Infection in Women: a Comparison of Four Antibiotics BJGP Open. Oct, 2017 | Pubmed ID: 30564681 Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment PharmacoEconomics. Oct, 2017 | Pubmed ID: 28674845 Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews PharmacoEconomics. Sep, 2017 | Pubmed ID: 28560492 Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. 03, 2017 | Pubmed ID: 28292475 The Cost-effectiveness of Real-time Pulmonary Artery Pressure Monitoring in Heart Failure Patients: a European Perspective European Journal of Heart Failure. 05, 2017 | Pubmed ID: 28176424 Cost Effectiveness of Using Cognitive Screening Tests for Detecting Dementia and Mild Cognitive Impairment in Primary Care International Journal of Geriatric Psychiatry. 12, 2017 | Pubmed ID: 27874210 Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease Has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal PharmacoEconomics. 01, 2017 | Pubmed ID: 27506954 Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 02, 2017 | Pubmed ID: 27492450 The RAPID-CTCA Trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a Multicentre Parallel-group Randomised Trial to Compare Early Computerised Tomography Coronary Angiography Versus Standard Care in Patients Presenting with Suspected or Confirmed Acute Coronary Syndrome: Study Protocol for a Randomised Controlled Trial Trials. 12, 2016 | Pubmed ID: 27923390 Economic Impact of Tegaderm Chlorhexidine Gluconate (CHG) Dressing in Critically Ill Patients Journal of Infection Prevention. 09, 2016 | Pubmed ID: 27582899 Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. Mar-Apr, 2016 | Pubmed ID: 27021745 Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective PharmacoEconomics. 08, 2016 | Pubmed ID: 26892974 Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. Jan, 2016 | Pubmed ID: 26797229 Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes Medical Decision Making : an International Journal of the Society for Medical Decision Making. 10, 2015 | Pubmed ID: 26377675 The Return of Public Health to Local Government in England: Changing the Parameters of the Public Health Prioritization Debate? Public Health. Sep, 2015 | Pubmed ID: 26298589 High-sensitivity Troponin Assays for the Early Rule-out or Diagnosis of Acute Myocardial Infarction in People with Acute Chest Pain: a Systematic Review and Cost-effectiveness Analysis Health Technology Assessment (Winchester, England). Jun, 2015 | Pubmed ID: 26118801 Pre-hospital Non-invasive Ventilation for Acute Respiratory Failure: a Systematic Review and Cost-effectiveness Evaluation Health Technology Assessment (Winchester, England). Jun, 2015 | Pubmed ID: 26102313 Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective PharmacoEconomics. Nov, 2015 | Pubmed ID: 26017401 Cost-effectiveness of Out-of-Hospital Continuous Positive Airway Pressure for Acute Respiratory Failure Annals of Emergency Medicine. May, 2015 | Pubmed ID: 25737210 Resource Modelling: the Missing Piece of the HTA Jigsaw? PharmacoEconomics. Mar, 2015 | Pubmed ID: 25411095 The Economics of Cardiac Biomarker Testing in Suspected Myocardial Infarction Clinical Biochemistry. Mar, 2015 | Pubmed ID: 25173750 Systematic Review and Modelling of the Cost-effectiveness of Cardiac Magnetic Resonance Imaging Compared with Current Existing Testing Pathways in Ischaemic Cardiomyopathy Health Technology Assessment (Winchester, England). Sep, 2014 | Pubmed ID: 25265259 Telemonitoring After Discharge from Hospital with Heart Failure: Cost-effectiveness Modelling of Alternative Service Designs BMJ Open. Sep, 2013 | Pubmed ID: 24048626 Multiple Criteria Decision Analysis for Health Technology Assessment Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. Dec, 2012 | Pubmed ID: 23244821 Cost-effectiveness of Presentation Versus Delayed Troponin Testing for Acute Myocardial Infarction Heart (British Cardiac Society). Oct, 2012 | Pubmed ID: 22865867 Establecer un modelo de córnea ex vivo porcina para estudiar tratamientos farmacológicos contra la queratitis bacteriana Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Imunologia e Infecção
Establecer un modelo de córnea ex vivo porcina para estudiar tratamientos farmacológicos contra la queratitis bacteriana Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Imunologia e Infecção